Sun Pharma Managing Director Kirti Ganorkar stated that improved access to new obesity and diabetes drugs, specifically GLP-1 receptor agonists, will be a significant growth driver for India's pharmaceutical industry. He noted India's transformation into a global weight management hub due to rising lifestyle diseases. Dr. Reddy's Chairman Satish Reddy emphasized innovation and accessible risk capital for India to become a pharmaceutical innovation hub, projecting a positive outlook for the sector.